Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817674 · ClinicalTrials.gov registry record
Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 353
- Enrollment target
NCT00817674 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 353 participants.
The verdict
NCT00817674 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 353 participants
- Enrollment target
Study Summary
To test if usual at home night time sleep duration as measured with activity monitors and questionnaires will predict changes in kidney function as measured by kidney filtration rate and of cardiovascular function as measured by C-reactive protein in the blood. The study will explore the role of decreased sleep time or decreased sleep quality as a non-traditional risk factor for the progression of CKD and for the development of cardiovascular disease in CKD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00817674
The ClinicalTrials.gov registry entry for NCT00817674 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 353 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00817674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00817674 about?
NCT00817674 is a clinical study titled "Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy". To test if usual at home night time sleep duration as measured with activity monitors and questionnaires will predict changes in kidney function as measured by kidney filtration rate and of cardiovascular function as measured by C-reactive protein in the blood. The study will explore the role of dec...
What is the current status of trial NCT00817674?
This trial is currently completed. The enrollment target is 353 participants. The study started on 2007-11. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00817674?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.